DR. MARTIN GRUND SELECT ABSTRACTS & PUBLICATIONS Grund, Dr. Martin and Farmer, Dr. Stacey J. (2012) "Brüstle v Greenpeace: The End of The Road for Human Embryonic Stem Cell Patents", Bio-Science Law Review 2012, Vol. 12, Issue 2. Grund, Dr. Martin (2011) "Anmerkungen zum Urteil C-34/10 des EuGH über die Auslegung in Bezug auf die Biopatentrichtlinie und embryonale Stammzellen in der Sache Brüstle v. Greenpeace", Mitteilungen der Patentanwälte, pp. 514- 515. Grund, Dr. Martin (2011) "EuGH verbietet Patentierung von humanen embryonalen Stammzellen" (ECJU forbids the patenting of human embryonic stem cells), BIOspektrum | 07.11 | 17. Jahrgang, p. 832. Grund, Dr. Martin and Farmer, Dr. Stacey J. (2011) "The EU Stem Cell Debate: Can Patenting Stem Cell Innovations be Done Morally?", Case C34/10 Brüstle v. Greenpeace – AG Bot’s Opinion, Bio-Science Law Review, Vol. 11, Issue 6, pp. 187-192. Farmer, Dr. Stacey J. and Grund, Dr. Martin (2011) "Patent Pending? EPO Decision Provides Guidance", Bio-Science Law Review, Vol. 11, Issue 2, pp. 62-66. Grund, Dr. Martin, Michel, Dr. Sara and Farmer, Dr. Stacey J. (2010) "European Court of Justice to Decide the Fate of Patenting Stem Cells in Europe", Bio-Science Law Review, Vol. 10, Issue 5, pp. 193-197. Grund, Dr. Martin (2010) "Patentierung von embryonalen Stammzellen" ("Patenting of Embryonic Stem Cells"), BIOspektrum, Vol 1, 2010, p. 121. Burda, Dr. Martin, Grund, Dr. Martin and Farmer, Dr. Stacey (2009) "G2/06: WARF EPO Upholds a Policy of Refusing European Patents for Inventions Covering Products that 'Can only be Obtained' via the Destruction of Human Embryos", Bio- Science Law Review, Vol. 9, Issue 6, pp. 239-242. Burda, Dr. Martin and Grund, Dr. Martin (2009) "Die Patentierbarkeit von Produkten aus menschlichen Embryonen" (The Patentability of Products (obtained) from Human Embryos), BIOspektrum, Vol. 2, 2009, p. 208-209. Farmer, Dr. Stacey J. and Grund, Dr. Martin (2009) "Revision of the European Patent Convention & Potential Impact on European Patent Practice", AIPLA Quarterly Journal, Volume 36, Number 4, Fall 2008, pp. 419-453. Grund, Dr. Martin and Farmer, Dr. Stacey J. (2008) "The ABCs of the EPC 2000", Managing Intellectual Property, SPECIAL ISSUE: Germany & EPO Focus, published in April, 2008, pp. 85-88. Trips-Herbert, Dr. and Grund, Dr. Martin (2007) "Die Früchte des verbotenen Baumes? Die Patentierung von Stammzellen nach dem 'Brüstle-Urteil' des Bundespatentgerichts und mögliche Fernwirkungen für die pharmazeutische Industrie" (The Fruit of the Forbidden Tree? The Patentability of Stem Cells after the 'Brüstle Decision" (of the German Federal Patent Court) and Possible Lasting Effects for the Pharmaceutical Industry), Pharma Recht (PharmR), Vol. 10, 29. Jahrgang, p. 397. Grund, Dr. Martin (2007) The London Agreement: "Das Europäische Patent wird günstiger!" (The European Patent Will be Less Expensive!") BIOspektrum, Vol. 07.07, p. 810. Grund, Dr. Martin, Richly, Dr. Erik, and Farmer, Dr. Stacey J. (2007) "Patentability of Embryonic Stem Cells in Germany", Commentary on the German Federal Patent Court decision of December 5, 2006, Bio-Science Law Review, Vol. 8, Issue 4, pp. 164-166. Grund, Dr. Martin, Richly, Dr. Erik, and Farmer, Dr. Stacey J. (2007) "Das 'kleine Patent' für biotechnologische Erfindungen" ("The 'petty patent' for biotechnology inventions"), BIOspektrum, Vol. 02.07, pp. 211-212. Grund, Dr. Martin (2007) “Umstrittene BPatG - Entscheidung zu humanen embryonalen Stammzellen" ("Controversial German Federal Patent Court Ruling - Decision regarding human embryonic stem cells") BIOspektrum, Vol. 01.07, p. 99. Grund, Dr. Martin, Richly, Dr. Erik, and Farmer, Dr. Stacey J. (2006) "Is German Utility Model Protection Available for Biotechnology Inventions?", Bio-Science Law Review, Vol. 8, Issue 3, pp. 123-125. Dr. Martin Grund and Dr. Martin Burda, (2005) “The new German patent law fails to transpose EU directive 98/44/EC.” Bio-Science Law Review, Volume 7, Issue 3, pp. 128-129. M. Grund and M. R. Burda. (2005) “Welche Folgen hat die Umsetzung der Biopatentrichtlinie auf die Patentierbarkeit biotechnologischer Erfindungen in Deutschland?" BIOspektrum, p. 739. Patentierbarkeit embyronaler Stammzellen (Patentability of Embryonic Stem Cells), Mitteilungen der deutsche Patentanwälte, pp. 49-56 (2004). Patentierbarkeit menschlicher embryonaler Stammzellen (Patentability of Human Embryonic Stem Cells), BIOspektrum, pp. 275-277 (2004). Patenting of Biotechnology Inventions in Europe – New Developments, Bio-Science Law Review, pp. 6-11 (2003). Das Ende des Hochschullehrerprivilegs, BIOspektrum, p. 230 (2002). Amendment of the German Employee Invention Act, Bio-Science Law Review, p. 18 (2002). Kein Patentschutz für menschliche Klonierverfahren (No Patent Protection for Human Cloning Procedures), Bielefelder Universitätszeitung, Nr. 205/2001, pp. 44-46 (2001). Will The Human Genome Soon Be Patented? Mondaq (2001) (see http://www.mondaq.com). Patentierbarkeit von transgenen Tieren (Patentability of Transgenic Animals), Mitteilung der deut. Patentanwälte, pp. 328-331 (2000). Transgene Pflanzen und Tiere sind in Europa patentierbar (Transgenic Plants and Animals are Patentable in Europe), BIOspektrum, p. 92 (2000). Ist das menschliche Genom bald patentgeschützt (Is the Human Genome soon patentable)? BIOspektrum, p. 44 (2000). Are Transgenic Plants and Animals now Patentable under the EPC? Bio-Science Law Review, 1999/2000,(2), pp. 51-55. Patentability of ESTs under the EPC, Bio-Science Law Review, Vol. 3, pp. 106-109 (1998). Patentierung des Relaxin-Gens (Patentability of the Relaxin Gene Family), Dt. Ärztebl., Vol. 93: A2384-2388 (1996). Patentierung von Teilen des Erbguts (Patentability of Partial DNA Sequences), Mitteilungen der deutsche Patentanwälte, 339 (1995). SELECT SPEAKING ENGAGEMENTS Regular Lecturer at the Santa Clara University School of Law (annual summer program for International and Comparative Intellectual Property Law; Munich, Germany), 2003-2011. Invited speaker, Wellcome Trust in London, England, Day symposium entitled "Embryonic Stem Cell Research: Beyond Brüstle vs Greenpeace", December 21, 2011. Invited Speaker, Biotech Patenting, C5 Conference, Munich, Germany, March 17-18, 2010 Invited Speaker for the "Second Annual Conference on Recombinant Therapeutics" held February 25-27, 2008, Berlin, Germany. Lecturer, "Patentability of Biotechnology Inventions in Europe", University of Bonn (Germany), March 19, 2007. Lecturer, First International Workshop on Mini-Circle DNA, "Minicircle Patent Situation, An Overview", held at the University of Bielefeld (Germany), February 22, 2007. European Tissue Engineering Society, 4th Annual Meeting 2005 (Munich, Germany), "Patenting of Biotechnology Inventions in Europe", September 2005. Patentrecht Biotechnologie (Biotecnhology Patent Law Series), TÜV-Akademie, 2001, 2002 2003, 2004. Updates in Patent Prosecution: A European Perspective; Participant on a panel devoted to International Patent Law, BIO (Biotechnology Industry Organization) Conference, San Diego, June, 2001. Patentability of transgenic plants, animals and ESTs under the EPC, Biotechnology 2000; 11th International Biotechnology Symposium and Exhibition, Berlin, September, 2000. Patent and Licensing Issues of Cell Culture Systems; Cell Culture and other Alternative Methods for Drug Delivery, Saarbrücken, February, 2000. Patenting Biotechnology Outside the US with Particular Emphasis on the European Patent Office and Germany; Conference on Biotechnology, Palo Alto, December, 1998. |
| Grund IP Group ● Nikolaistrasse 15, D-80802, Munich, GERMANY ● FON: + 49 (89) 54 80 19-0 ● FAX: + 49 (89) 54 80 19-10 |